Reducing the Risk of Vaccine Preventable Diseases During the COVID-19 Pandemic
Adult and pediatric gastroenterologists and hepatologists often manage patients who are at increased risk for infections as a consequence of their disease or because of their use of immunosuppressive agents. Important patient groups to consider include those with inflammatory bowel disease (IBD), autoimmune hepatitis, cirrhosis, and those after a liver transplant. When including patients older than the age of 65 and the 3% of the general population who are immunosuppressed, it is clear that a substantial number of patients seen in gastroenterology and hepatology practices are at increased risk for infection.
Source: Clinical Gastroenterology and Hepatology - Category: Gastroenterology Authors: Megan Lutz, Mary S. Hayney, Francis A. Farraye, Freddy Caldera Tags: Here and Now: Clinical Practice Source Type: research
More News: Autoimmune Disease | Cirrhosis | COVID-19 | Gastroenterology | Hepatitis | Hepatitis Vaccine | Inflammatory Bowel Disease | Liver | Liver Transplant | Pandemics | Pediatrics | Transplant Surgery | Transplants | Urology & Nephrology | Vaccines